Elucidating the interactions between the adhesive and transcriptional functions of β-catenin in normal and cancerous cells

Journal of Theoretical Biology

Volumn 247, Issue 1, 2007, Pages 77-102

  van Leeuwen, Ingeborg M M ^a   Byrne, Helen M ^a   Jensen, Oliver E ^a   King, John R ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

Adherens junction; APC mutation; Colorectal cancer; Crypt dynamics

Indexed keywords

BETA CATENIN; TRANSCRIPTION FACTOR; WNT PROTEIN;

ADHESION; CANCER; MUTATION; NUMERICAL MODEL; PROTEIN; SIGNAL; TUMOR;

ANALYTIC METHOD; ARTICLE; BEHAVIOR; CANCER CELL; CELL ADHESION; CELL JUNCTION; COLORECTAL CANCER; COMPUTER MODEL; CONTROLLED STUDY; HUMAN; HUMAN CELL; MATHEMATICAL MODEL; MUTATION; PHENOTYPE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN INTERACTION; SIMULATION;

BETA CATENIN; CADHERINS; CELL ADHESION; CELL TRANSFORMATION, NEOPLASTIC; COLORECTAL NEOPLASMS; GENES, APC; HUMANS; MODELS, BIOLOGICAL; MUTATION; NEOPLASM PROTEINS; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC; WNT PROTEINS;

EID: 34247335443     PISSN: 00225193     EISSN: 10958541     Source Type: Journal    
DOI: 10.1016/j.jtbi.2007.01.019     Document Type: Article

References (126)

1. Aberle H., Butz S., Stappert J., Weissig H., Kemler R., and Hoschuetzky H. Assembly of the cadherin-catenin complex in vitro with recombinant proteins. J. Cell Sci. 12 (1994) 3655-3663
2. Aberle H., Bauer A., Stappert J., Kispert A., and Kemler R. β-catenin is a target for the ubiquitin-proteasome pathway. EMBO J. 16 (1997) 3797-3804
3. Alarcón T., Byrne H.M., and Maini P.K. Towards whole-organ modelling of tumour growth. Prog. Biophys. Mol. Biol. 85 (2004) 451-472
4. Albuquerque C., Breukel C., Van der Luijt R., Fidalgo P., Lage P., Slors F., Leitão C.N., Fodde R., and Smits R. The 'just-right' signaling model: APC somatic mutations are selected based on a specific level of activation of the β-catenin signaling cascade. Human Mol. Gen. 11 (2002) 1549-1560
5. Bafico A., Liu G., Goldin L., Harris V., and Aaronson S.A. An autocrine mechanism for constitutive Wnt pathway activation in human cancer cells. Cancer Cell 6 (2004) 497-506
6. Batlle E., Henderson J.T., Beghtel H., Van den Born M.M.W., Sancho E., Huls G., Meeldijk J., Robertson J., Van de Wetering M., Pawson T., and Clevers H. β-catenin and TCF mediate cell positioning in the intestinal epithelium by controlling the expression of EphB/EphrinB. Cell 111 (2002) 251-263
7. Behrens J. The role of the Wnt signalling pathway in colorectal tumorigenesis. Biochem. Soc. Trans. 33 (2005) 672-675
8. Bell E., Muñoz SanJuán I., Altmann C.R., Vonica A., and Brivanlou A.H. Cell fate specification and competence by Coco, a maternal BMP, TGF β and Wnt inhibitor. Development 130 (2003) 1381-1389
9. Bienz M. β-catenin: a pivot between cell adhesion and Wnt signalling. Curr. Biol. 15 (2005) R64-R67
10. Bradley R.S., Cowin P., and Brown A.M. Expression of Wnt-1 in PC12 cells results in modulation of plakoglobin and E-cadherin and increased cellular adhesion. J. Cell Biol. 123 (1993) 1857-1865
11. Brembeck F.H., Schwarz-Romond T., Bakkers J., Wilhelm S., Hammerschmidt M., and Birchmeier W. Essential role of BCL9-2 in the switch between β-catenin's adhesive and transcriptional functions. Gen. Dev. 18 (2004) 2225-2230
12. Brembeck F.H., Rosário M., and Birchmeier W. Balancing cell adhesion and Wnt signaling, the key role of β-catenin. Curr. Opinion Genet. Dev. 16 (2006) 51-59
13. Brennan K.R., and Brown A.M.C. Wnt proteins in mammary development and cancer. J. Mammary Gland Biol. Neoplasia 9 (2004) 119-131
14. Cadigan K.M., and Liu Y.I. Wnt signaling: complexity at the surface. J. Cell Sci. 119 (2006) 395-402
15. Cavallaro U., Schaffhauser B., and Christofori G. Cadherins and the tumour progression: is it all in a switch?. Cancer Lett. 176 (2002) 123-128
16. Cavalli L.R., and Liang B.C. Mutagenesis, tumorigenicity, and apoptosis: are the mitochondria involved?. Mut. Res. 398 (1998) 19-26
17. Chevallier N.L., Soriano S., Kang D.E., Masliah E., Hu G., and Koo E.H. Perturbed neurogenesis in the adult hippocampus associated with preselin-1 A246E mutation. Am. J. Pathol. 167 (2005) 151-159
18. Cho K.-H., Baek S., and Sung M.-H. Wnt pathway mutations selected by optimal β-catenin signaling for tumorigenesis. FEBS Lett. 580 (2006) 3665-3670
19. Christofori G. New signals from the invase front. Nature 441 (2006) 444-450
20. Christofori G., and Semb H. The role of the cell-adhesion molecule E-cadherin as a tumor-suppressor gene. Trends Biochem. Sci. 24 (1999) 73-76
21. Ciechanover A. The ubiquitin-proteosome pathway: on protein death and cell life. EMBO J. 17 (1998) 7151-7160
22. Clapper M.L., Coudry J., and Chang W.C. β-catenin-mediated signaling: a molecular target for early chemopreventive intervention. Mut. Res. 555 (2004) 97-105
23. Conacci-Sorrell M., Simcha I., Ben-Yedidia T., Blachman J., Savagner P., and Ben-Ze'ev A. Autoregulation of E-cadherin expression by cadherin-cadherin interactions: the roles of β-catenin signaling, Slug, and MAPK. J. Cell Biol. 163 (2003) 847-857
24. Dajani R., Fraser E., Roe S.M., Yeo M., Good V., Thompson V., Dale T.C., and Pearl L.H. Structural basis for recruitment of glycogen synthase kinase 3 β to the axin-APC scaffold complex. EMBO J. 22 (2003) 494-501
25. Daniels D.L., and Weis W.I. β-catenin directly displaces Groucho/TLE repressors from Tcf/Lef in Wnt-mediated transcription activation. Nat. Struct. Mol. Biol. 12 (2005) 364-371
26. Daniels D.L., Eklof-Spink K., and Weis W.I. β-catenin: molecular plasticity and drug design. Trends Biochem. Sci. 26 (2001) 672-678
27. Davis M.A., Ireton R.C., and Reynolds A.B. A core function for p120-catenin in cadherin turnover. J. Cell Biol. 163 (2003) 525-534
28. Dihlmann S., Klein S., and Doeberitz M.M.K. Reduction of β-catenin/T-cell transcription factor signaling by aspirin and indomethacin is caused by an increased stabilization of phosphorylated β-catenin. Mol. Cancer Ther. 2 (2003) 509-516
29. Van Es J.H., Jay P., Gregorieff A., Van Gijn M.E., Jonkheer S., Hatzis P., Thiele A., Van den Born M., Begthel H., Brabletz T., Taketo M.M., and Clevers H. Wnt signalling induces maturation of Paneth cells in intestinal crypts. Nat. Cell Biol. 7 (2005) 381-386
30. Fagotto F., Funayama N., Gluck U., and Gumbiner B.M. Binding to cadherins antagonizes the signaling activity of β-catenin during axis formation in Xenopus. J. Cell Biol. 132 (1996) 1105-1114
31. Fearon E.R., and Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 61 (1990) 759-767
32. Filali M., Cheng N., Abbott D., Leontiev V., and Engelhardt J.F. Wnt-3A/β-catenin signaling induces transcription from the LEF-1 promoter. J. Biol. Chem. 277 (2002) 33398-33410
33. Fodde R. The multiple functions of tumour suppressors: it's all in APC. Nat. Cell Biol. 5 (2003) 190-192
34. Fodde R., Smits R., and Clevers H. APC, signal transduction and genetic instability in colorectal cancer. Nat. Rev. Cancer 1 (2001) 55-67
35. Frixen U.H., Behrens J., Sachs M., Eberle G., Voss B., Warda A., Löchner D., and Birchmeier W. E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells. J. Cell Biol. 113 (1991) 173-185
36. Gaspar C., and Fodde R. APC dosage effects in tumorigenesis and stem cell differentiation. Int. J. Dev. Biol. 48 (2004) 377-386
37. Giles R.H., Van Es J.H., and Clevers H. Caught up in a Wnt storm: Wnt signaling in cancer. Biochim. Biophys. Acta 1653 (2003) 1-24
38. Gonzalez-Sancho J.M., Aguilera O., García J.M., Pendas-Franco N., Pena C., Cal S., García de Herreros A., Bonilla F., and Muñoz A. The Wnt antagonist Dickkopf-1 gene is a downstream target of β-catenin/TCF and is downregulated in human colon cancer. Oncogene 24 (2004) 1098-1103
39. Gonzalez-Sancho J.M., Brennan K.R., Castelo-Soccio L.A., and Brown A.M. Wnt proteins induce Dishevelled phosphorylation via an LPR5/6 independent mechanism, irrespective of their ability to stabilize β-catenin. Mol. Cell. Biol. 24 (2004) 4757-4768
40. Gottardi C.J., and Gumbiner B.M. Distinct molecular forms of β-catenin are targeted to adhesive or transcriptional complexes. J. Cell Biol. 167 (2004) 339-349
41. Gottardi C.J., Wong E., and Gumbiner B.M. E-cadherin suppresses cellular transformation by inhibiting β-catenin signaling in an adhesion-independent manner. J. Cell Biol. 153 (2001) 1049-1059
42. Graham T.A., Weaver C., Mao F., Kimmelman D., and Xu W. Crystal structure of the β-catenin/Tcf complex. Cell 103 (2000) 885-896
43. Graham T.A., Ferkey D.M., Mao F., Kimmelman D., and Xu W. Tcf4 can specifically recognize β-catenin using alternative conformations. Nat. Str. Biol. 8 (2001) 1048-1052
44. Gumbiner B.M. Regulation of cadherin adhesive activity. J. Cell Biol. 148 (2000) 399-403
45. Ha N.C., Tonozuka T., Stamos J.L., Choi H.J., and Weis W.I. Mechanism of phosphorylation-dependent binding of APC to β-catenin and its role in β-catenin degradation. Mol. Cell 15 (2004) 511-521
46. Hackman A.S. The Wnt signalling pathway in retinal degenerations. IUBMB Life 57 (2005) 381-388
47. Harris T.J.C., and Peifer M. Decisions, decisions: β-catenin chooses between adhesion and transcription. Trends Cell Biol. 15 (2005) 234-237
48. He T.C., Sparks A.B., Rago C., Hermeking H., Zawel L., da Costa L.T., Morin P.J., Vogelstein B., and Kinzler K.W. Identification of c-Myc as a target of the APC pathway. Science 281 (1998) 1509-1512
49. Heasman J., Crawford A., Goldstone K., Garner-Hamrick P., Gumbiner B., McCrea P., Kintner C., Noro C.Y., and Wylie C. Overexpression of cadherins and underexpression of β-catenin inhibit dorsal mesoderm induction in early Xenopus embryos. Cell 79 (1994) 791-803
50. Herzig, M., Savarese, F., Novatchkova, M., Semb, H., Christofori, G., 2006. Tumor progression induced by the loss of E-cadherin independent of β-catenin/Tcf-mediated Wnt signaling. Oncogene 1-9.
51. Hinck L., Nelson W.J., and Papkoff J. Wnt-1 modulates cell-cell adhesion in mammalian cells by stabilizing β-catenin binding to the cell adhesion protein cadherin. J. Cell Biol. 124 (1994) 729-741
52. Holcombe R.F., Marsh J.L., Waterman M.L., Lin F., Milovanovic T., and Truong T. Expression of Wnt ligands and Frizzled receptors in colonic mucosa and in colon carcinoma. Mol. Pathol. 55 (2002) 220-226
53. Hsieh J.C., Kodjabachian L., Rebbert M., Rattner A., Smallwood P.M., Harryman-Samos C., Nusse R., Dawid I.B., and Nathans J. A new secreted protein that binds to Wnt proteins and inhibits their activities. Nature 398 (1999) 431-436
54. Huber A.H., and Weis W.I. The structure of the β-catenin/E-cadherin complex and the molecular basis of diverse ligand recognition by β-catenin. Cell 105 (2001) 391-402
55. Huber A.H., Stewart D.B., Laurents D.V., Nelson W.J., and Weis W.I. The cadherin cytoplasmic domain is unstructured in the absence of β-catenin. A possible mechanism for regulating cadherin turnover. J. Biol. Chem. 276 (2001) 12301-12309
56. Ilyas M. β-catenin mutations in cell lines established from human colorectal cancers. Proc. Natl Acad. Sci. USA 94 (1997) 10330-10334
57. Ilyas M. Wnt signalling and the mechanistic basis of tumour development. J. Pathol. 205 (2005) 130-144
58. Jamora C., and Fuchs E. Intercellular adhesion, signalling and the cytoskeleton. Nat. Cell Biol. 4 (2002) 101-108
59. Jamora C., DasGupta R., Kocieniewski P., and Fuchs E. Link between signal transduction, transcription and adhesion in epithelial bud development. Nature 422 (2003) 317-322
60. Jeneson J.A., Westerhoff H.V., and Kushmerick M.J. A metabolic control analysis of kinetic controls in ATP free energy metabolism in contracting skeletal muscle. Am. J. Phys. 279 (2000) 813
61. Jho E., Zhang T., Domon C., Joo C.K., Freund J.N., and Costanti F. Wnt/β-catenin/Tcf signaling induces the transcription of Axin2, a negative regulator of the signaling pathway. Mol. Cell. Biol. 22 (2002) 1172-1183
62. Jones S.E., and Jomary C. Secreted Frizzled-related proteins: searching for relationships and patterns. BioEssays 24 (2002) 811-820
63. Kapitanović S., Čačev T., Antica M., Kralj M., Cavrić G., Pavelić K., and Spaventi R. Effect of indomethacin on E-cadherin and β-catenin expression in HT-29 colon cancer cells. Exp. Mol. Pathol. 80 (2006) 91-96
64. Kielman M.F., Rindapää M., Gaspar C., Van Poppel N., Breukel C., Van Leeuwen S., Taketo M.M., Roberts S., Smits R., and Fodde R. APC modulates embryonic stem-cell differentiation by controlling the dosage of β-catenin signaling. Nat. Gen. 32 (2002) 594-605
65. Kim K.M., Pang K.M., Evans M., and Hay E.D. Overexpression of β-catenin induces apoptosis independent of its transactivation function with LEF-1 or the involvement of major G1 cell cycle regulators. Mol. Biol. Cell 11 (2000) 3509-3523
66. Kinzler K., and Vogelstein B. Lessons from hereditary colorectal cancer. Cell 87 (1996) 159-170
67. Kishida M., Hino S.I., Michiue T., Yamamoto H., Kishida S., Fukui A., Asashima M., and Kikuchi A. Synergistic activation of the Wnt signaling pathway by Dvl and casein kinase I ε{lunate}. J. Biol. Chem. 276 (2001) 33147-33155
68. Koay M.A., and Brown M.A. Genetic disorders of the LRP5-Wnt signalling pathway affecting the skeleton. Trends Mol. Med. 11 (2005) 129-137
69. Korinek V., Barker N., Moerer P., Donselaar E., Huls G., Peters P.J., and Clevers H. Depletion of epithelial stem-cell compartments in the small intestine of mice lacking Tcf-4. Nat. Gen. 19 (1998) 379-383
70. Kramps T., Peter O., Brunner E., Nellen D., Froesch B., Chatterjee S., Murone M., Zülling S., and Basler K. Wnt/Wingless signaling requires BCL9/Legless-mediated recruitments of Pygopus to the nuclear β-catenin-TCF complex. Cell 109 (2002) 47-60
71. Von Kries J.P., Winbeck G., Asbrand C., Schwarz-Romond T., Sochnikova N., Dell'Oro A., Behrens J., and Birchmeier W. Hot spots in β-catenin for interactions with LEF-1, conduction and APC. Nat. Str. Biol. 7 (2000) 800-807
72. Krüger R., and Heinrich R. Model reduction and analysis of robustness for the Wnt/β-catenin signal transduction pathway. Genome Inf. 15 (2004) 138-148
73. Kuphal F., and Behrens J. E-cadherin modulates Wnt-dependent transcription in colorectal cancer cells but does not alter Wnt-independent gene expression in fibroblasts. Exp. Cell. Res. 312 (2006) 457-467
74. Lee E., Salic A., Krüger R., Heinrich R., and Kirschner M.W. The roles of APC and axin derived from experimental and theoretical analysis of the wnt pathway. Pub. Lib. Sci. Biol. 1 (2003) 116-132
75. Van Leeuwen I.M.M., Byrne H.M., Jensen O.E., and King J.R. Crypt dynamics and colorectal cancer: advances in mathematical modelling. Cell Prolif. 39 (2006) 157-181
76. Leung J.Y., Kolligs F.T., Wu R., Zhai Y., Kuick R., Hanash S., Cho K.R., and Fearon E.R. Activation of AXIN2 expression by β-catenin-T cell factor. A feedback repressor pathway regulating Wnt signalling. J. Biol. Chem. 277 (2002) 21657-21665
77. Li Q., Ishikawa T., Oshima M., and Taketo M.M. The threshold level of adenomatous polyposis coli protein for mouse intestinal tumorigenesis. Cancer Res. 65 (2005) 8622-8627
78. Liu C., Li Y., Semenov M., Han C., Baeg G.H., Zhang Z., Lin X., and He X. Control of β-catenin phosphorylation/degradation by a dual-kinase mechanism. Cell 108 (2002) 837-847
79. Liu J., Stevens J., and Rote C.A. Siah-1 mediates a novel β-catenin degradation pathway linking p53 to the adenomatous polyposis coli protein. Mol. Cell 7 (2001) 837-847
80. Mao B., Wang J., Liu B., Pan W., Farr G.H., Flynn C., Yuan H., Takada S., Kimelman D., and Li L.D.W. Low-density lipoprotein receptor-related protein-5 binds to axin and regulates the canonical Wnt signalling pathway. Mol. Cell 7 (2001) 801-809
81. Mao B., Wu W., Li Y., Hoppe D., Stannek P., Glinka A., and Niehrs C. LDL-receptor-related protein 6 is a receptor for Dickkopf proteins. Nature 411 (2001) 321-325
82. Mao B., Wu W., Davidson G., Marhold J., Li Y., Mechler B.M., Delius H., Hoppe D., Stannek P., Walter C., Glinka A., and Niehrs C. Kremen proteins are Dickkopf receptors that regulate Wnt/β-catenin signalling. Nature 417 (2002) 664-667
83. Margulis A., Zhang W., Alt-Holland A., Crawford H.C., Fusenig N.E., and Garlick J.A. E-cadherin suppression accelerates squamous cell carcinoma progression in three-dimensional, human tissue constructs. Cancer Res. 65 (2005) 1783-1791
84. Matsuzawa S.I., and Reed J.C. Siah-1, SIP, and Ebi collaborate in a novel pathway for β-catenin degradation linked to p53 responses. Mol. Cell 7 (2001) 915-926
85. Miller J.R. The Wnts. Genome Biol. 3 (2002) 3001.1-3001.15
86. Moon R.T., Bowerman B., Boutros M., and Perrimon N. The promise and perils of Wnt signaling through β-catenin. Science 31 (2002) 1644-1646
87. Morin P.J., Sparks A.B., Korinek V., Barker N., Vogelstein B., and Kinzler K.W. Activation of β-catenin-TCF signaling in colon cancer by mutations in β-catenin or APC. Science 275 (1997) 1787-1790
88. Nelson W.J., and Nusse R. Convergence of Wnt, β-catenin, and cadherin pathways. Science 303 (2004) 1483-1487
89. Noble D. Modeling the heart-from genes to cell to the whole organ. Science 295 (2002) 1678-1682
90. Novák B., and Tyson J.J. A model for restriction point control of the mammalian cell cycle. J. Theor. Biol. 230 (2004) 563-579
91. Nusslein-Volhard C., and Wieschaus E. Mutations affecting segment number and polarity in Drosophila. Nature 287 (1980) 795-801
92. Ozawa M., Baribault H., and Kemler R. The cytoplasmic domain of the cell adhesion molecule uvomorulin associates with three independent proteins structurally related in different species. EMBO J. 8 (1989) 1711-1717
93. Perez-Moreno M., Jamora C., and Fuchs E. Sticky business: orchestrating cellular signals at adherens junctions. Cell 112 (2003) 535-548
94. Perl A.K., Wilgenbus P., Dahl U., Semb H., and Christofori G. A causal role for E-cadherin in the transition from adenoma to carcinoma. Nature 392 (1998) 190-193
95. Piccolo S., Agius E., Leyns L., Bhattacharyya S., Grunz H., Bouwmeester T., and De Robertis E.M. The head inducer Cerberus is a multifunctional antagonist of Nodal, BMP and wnt signals. Nature 397 (1999) 707-710
96. Pokutta S., and Weis W.I. Structure of the dimerization and β-catenin-binding region of α-catenin. Mol. Cell 5 (2000) 533-543
97. Polakis P. The oncogenic activation of β-catenin. Curr. Opinion Gen. Dev. 9 (1999) 15-21
98. Radtke F., and Clevers H. Self-renewal and cancer of the gut: two sides of a coin. Science 307 (2005) 1904-1909
99. Ribba, B., Colin, T., Schnell, S., 2006. A multiscale mathematical model of cancer, and its use in analyzing irradiation therapies. Theor. Biol. Med. Model. 3, doi:10.1186/1742-4682-3-7.
100. Richards F.M., McKee S.A., Rajpar M.H., Cole T.R., Evans D.G., Jankowski J.A., McKeown C., Sanders D.S., and Maher E.R. Germline E-cadherin gene (CDH1) mutations predispose to familial gastric cancer and colorectal cancer. Hum. Mol. Genet. 8 (1999) 607-610
101. Roura S., Miravet S., Piedra J., García de Herreros A., and Dunach M. Regulation of E-cadherin/catenin association by tyrosine phosphorylation. J. Biol. Chem. 274 (1999) 36734-36740
102. Russello S.V., and Shore S.K. Src in human carcinogenesis. Front. Biosci. 9 (2004) 139-144
103. Sanson B., White P., and Vincent J.P. Uncoupling cadhering-based adhesion from Wingless signalling in Drosophila. Nature 383 (1996) 627-630
104. Shimamura K., Hirano S., McMahon A.P., and Takeichi M. Wnt-1-dependent regulation of local E-cadherin and α N-catenin expression in the embryonic mouse brain. Development 120 (1994) 22225-22234
105. Shtutman M., Zhurinsky J., Simcha I., Albanese C., D'Amico M., Pestell R., and Ben-Ze'ev A. The cycling-D1 gene is a target of the β-catenin/LEF-1 pathway. Proc. Natl Acad. Sci. USA 96 (1999) 5522-5527
106. Smits R., Hofland N., Edelman W., Geugien M., Jagmohan-Changur S., Albuquerque C., Breukel C., Kucherlapati R., Kielman M.F., and Fodde R. Somatic Apc mutations are selected upon their capacity to inactivate the β-catenin downregulating activity. Genes Chromosomes Cancer 29 (2000) 229-239
107. Staal F.J., and Clevers H.C. WNT signalling and haematopoiesis: a WNT-WNT situation. Nat. Rev. Immunol. 5 (2005) 21-30
108. Suzuki H., Watkins D.N., Jair K.W., Schuebel K.E., Markowitz S.D., Chen W.D., Pretlow T.P., Yang B., Akiyama Y., Van Engeland M., Toyota M., Tokino T., Hinoda Y., Imai K., Herman J.G., and Baylin S.B. Epigenetic inactivation of SFRP genes allows constitutive WNT signaling in colorectal cancer. Nat. Gen. 36 (2004) 417-422
109. 1 / S transition. Bioinformatics 20 (2004) 1506-1511
110. Swiatek W., Tsai I.C., Klimowski L., Pepler A., Barnette J., Yost H.J., and Virshup M. Regulation of casein kinase I ε{lunate} activity by Wnt signaling. J. Biol. Chem. 279 (2004) 13011-13017
111. Takada R., Hijikata H., Kondoh H., and Takada S. Analysis of combinatorial effects of Wnts and Frizzled on β-catenin/Armadillo stabilization and Dishevelled phosphorilation. Gen. Cell. 10 (2005) 919-928
112. Takemaru K.I., Yamaguchi S., Lee Y.S., Zhang Y., Carthew R.W., and Moon R.T. Chibby, a nuclear β-catenin-associated antagonist of the Wnt/Wingless pathway. Nature 422 (2002) 905-909
113. Tepass U. Adherens junctions: new insight into assembly, modulation and function. BioEssays 24 (2002) 690-695
114. Tetsu O., and McCormick F. β-catenin regulates expression of cyclinD1 in colon carcinoma. Nature 398 (1999) 422-426
115. Thompson B., Twnsley F., Rosin-Arbesfeld R., Musisi H., and Bienz M. A new nuclear component of the Wnt signalling pathway. Nat. Cell Biol. 4 (2002) 367-373
116. Tolwinski N.S., and Wieschaus E. A nuclear escort for β-catenin. Nat. Cell Biol. 6 (2004) 579-580
117. Tolwinski N.S., and Wieschaus E. Rethinking Wnt signalling. Trends Gen. 20 (2004) 177-181
118. Townsley F.M., Cliffe A., and Bienz M. Pygopus and Legless target Armadillo/β-catenin to the nucleus to enable its transcriptional co-activator function. Nat. Cell Biol. 6 (2004) 579-580
119. Üren A., Reichsman F., Anest V., Taylor W.G., Muraiso K., Bottaro D.P., Cumberledge S., and Rubin J.S. Secreted Frizzled-related Protein-1 binds directly to Wingless and is a biphasic modulator of Wnt signalling. J. Biol. Chem. 275 (2000) 1374-1382
120. Vleminckx K., Vakaet Jr. L., Mareel M., Fiers W., and Van Roy F. Genetic manipulation of E-cadherin expression by epithelial tumour cells reveals an invasion suppressor role. Cell 66 (1991) 107-119
121. Westendorf J.J., Kahler R.A., and Schroeder T.M. Wnt signaling in osteoblasts and bone disease. Gene 341 (2004) 19-39
122. Van de Wetering M., Sancho E., Verweij C., DeLau W., Oving I., Hurlstone A., Van der Horn K., Batlle E., Coudreuse D., Haramis A.P., Tjon-Pon-Fong M., Moerer P., Van den Born M., Soete G., Pals S., Eilers M., Medema R., and Clevers H. The β-catenin/TCF-4 complex imposes a crypt progenitor phenotype on colorectal cancer cells. Cell 111 (2002) 241-250
123. Wong H.C., Bourdelas A., Krauss A., Lee H.J., Shao Y., Wu D., Mlodzik M., Shi D.L., and Zheng J. Direct binding of the PDZ domain of Dishevelled to a conserved internal sequence in the C-terminal region of Frizzled. Mol. Cell 12 (2003) 1251-1260
124. Wu G., Xu G., Schulman B.A., Jeffrey P.D., Harper J.W., and Pavletich N.P. Structure of a β-catenin-TrCP1-Skp1-β-catenin complex: destruction motif binding and lysine specificity of the SCF(β-TrCP) ubiquitin ligase. Mol. Cell 11 (2003) 1445-1456
125. Xing Y., Clements W.K., and Kimelman D. Crystal structure of a β-catenin/axin complex suggests a mechanism for the β-catenin destruction complex. Gen. Dev. 17 (2003) 2753-2764
126. Xing Y., Clements W.K., Le Trong I., Hinds T.R., Stenkamp R., Kimelman D., and Xu W. Crystal structure of a β-catenin/APC complex reveals a critical role of APC phosphorylation in APC function. Mol. Cell 15 (2004) 523-533